Works matching IS 15747891 AND DT 2018 AND VI 12 AND IP 12
Results: 14
Nogo‐B promotes tumor angiogenesis and provides a potential therapeutic target in hepatocellular carcinoma.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2042, doi. 10.1002/1878-0261.12358
- By:
- Publication type:
- Article
Transcriptional upregulation of c‐MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2191, doi. 10.1002/1878-0261.12395
- By:
- Publication type:
- Article
Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2147, doi. 10.1002/1878-0261.12393
- By:
- Publication type:
- Article
Unscheduled HDAC4 repressive activity in human fibroblasts triggers TP53‐dependent senescence and favors cell transformation.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2165, doi. 10.1002/1878-0261.12392
- By:
- Publication type:
- Article
Using microarray‐based subtyping methods for breast cancer in the era of high‐throughput RNA sequencing.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2136, doi. 10.1002/1878-0261.12389
- By:
- Publication type:
- Article
A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy‐treated head and neck squamous cell carcinoma (HNSCC).
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2085, doi. 10.1002/1878-0261.12388
- By:
- Publication type:
- Article
Efficacy of nano‐particulated, water‐soluble erlotinib against intracranial metastases of EGFR‐mutant lung cancer.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2182, doi. 10.1002/1878-0261.12394
- By:
- Publication type:
- Article
Post‐transcriptional regulation of PIAS3 expression by miR‐18a in malignant mesothelioma.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2124, doi. 10.1002/1878-0261.12386
- By:
- Publication type:
- Article
Genome‐wide identification of a novel miRNA‐based signature to predict recurrence in patients with gastric cancer.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2072, doi. 10.1002/1878-0261.12385
- By:
- Publication type:
- Article
Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2009, doi. 10.1002/1878-0261.12383
- By:
- Publication type:
- Article
Targeting newly identified ERβ/TGF‐β1/SMAD3 signals with the FDA‐approved anti‐estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2055, doi. 10.1002/1878-0261.12377
- By:
- Publication type:
- Article
Role of TGF‐β1/miR‐382‐5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2102, doi. 10.1002/1878-0261.12387
- By:
- Publication type:
- Article
MicroRNA‐9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2023, doi. 10.1002/1878-0261.12352
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2007, doi. 10.1002/1878-0261.12131
- Publication type:
- Article